I worked over the entire research pipeline for our mobile app research start-up, largely related to psychedelic research. I helped and performed roles from market research, study design with world-wide researchers, ethics approval processes, survey creation, validated survey research, adapting to fit our app working with in-house tech team, liaising between stakeholders, study testing, feedback, marketing campaigns, study launch, data analysis, data dissemination, report writing for internal and external sources, grant applications, and more.Our goal was to help democratize science by bringing it out of the ivory tower and into the palm of your hand so folks from everywhere could participate, opening the doors for more diverse voices at the table.Our biggest study to date is Microdose.me with over 20,000 participants and 2 papers published in Nature Scientific Reports working with a global team of researcher including Paul Stamets, Jim Fadiman, Kim Kuypers, Zach Walsh, Pam Kryskow and more. Additionally, we investigated the relationship of microdosing and meditation with Beckley Foundation, anxiety and HPPD (HPPD and Anxiety, Do you see it?), the impact of psychedelics on the menstrual cycle (Code Red: Women and Psychedelics), psychedelics as therapies for combat veterans with PTSD with Saving Grace K9's, Ketamine-Assisted Psychotherapy, attitudes towards psychedelics with Diamond Therapeutics, microdosing and pain as well as microdosing and neurological disorders with Beckley Foundation, psilocybin as a therapy for frontline clinicians experiencing burnout (Dr. Tony Back, University of Washington), music and psychedelics with Wavepaths, impacts of COVID, sobriety and sleep, mental health tracker gratitude and healing with Louie Schwarztberg, and the impacts of breathwork with Our Breath Collective, and more. This wide range of studies meant digging in to research on many topics and working with a diverse group of researchers or community activists.

I brought to life a 10-week online educational course for practitioners and interested folks on the subject of psychedelic microdosing. This included the history, discovery, molecular structure, mechanism of action, neural pathways, current and historical research, microdosing and macrodosing practices, harm reduction, legal policies, and more for psilocybin, LSD, ayahuasca, ketamine, MDMA, peyote, and other substances. Additionally, I interviewed leaders in the psychedelic space and moderated Q&A sessions with participants (James Fadiman, Mark Haden, Dr. Zach Walsh, and more).This experience led me to dive deep into the history and research on these substances and translate the material to be accessible for a wide range of audience members. I also helped design and edit questions to check the knowledge absorption of the students.

Created an internal database using Notion to organize the field of psychedelic research findings to inform Quantified Citizen's 22,000 person (and counting) observational microdosing study, found at Microdose.me

Studied the nigrostriatal dopamine system in the leucine-rich repeat kinase 2 (LRRK2) G2019S mouse model of Parkinson's Disease using behaviour, in-vivo microdialysis with HPLC analysis, as well as slice electrophysiology using fast-scan cyclic voltammetry for field recordings of dopamine release and reuptake to elucidate alterations at multiple age points.

Studied chronic NMDA receptor dysfunction (schizophrenia model) via NR1 subunit deletion (with targeted AAV-Cre recombinase) in the medial pre-frontal cortex using behavioural assays, histology, and in-vivo microdialysis with high-performance liquid chromatography analysis.